医学
多发性骨髓瘤
耐火材料(行星科学)
扩展访问
来那度胺
内科学
肿瘤科
家庭医学
天体生物学
物理
作者
Lucio Gordan,Arielle G. Bensimon,Mu Fan,Nina Kim,Bingcao Wu,Dee Lin,Agne Paner,Jessica Fowler,A. Marshall,Suzy Van Sanden,Eric M. Ammann,J. Goble,Xinke Zhang,Hoa H. Le,Elissa E. Min,Louis P. Garrison
标识
DOI:10.1080/13696998.2025.2514909
摘要
Teclistamab was associated with significantly lower treatment costs and numerically lower cost per responder than elranatamab in triple class-exposed RRMM.
科研通智能强力驱动
Strongly Powered by AbleSci AI